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Abstract
Background: The high glucose levels typically occurring among adults with type 2 diabetes contribute to blood vessel injury
and complications such as blindness, kidney failure, heart disease, and stroke. Higher physical activity levels are associated with
improved glycemic control, as measured by hemoglobin A1C. A 1% absolute increase in A1C is associated with an 18% increased
risk for heart disease or stroke. Among Canadians with type 2 diabetes, we postulate that declines in walking associated with
colder temperatures and inclement weather may contribute to annual post-winter increases in A1C levels.
Methods: During this prospective cohort study being conducted in Montreal, Quebec, Canada, 100 men and 100 women with
type 2 diabetes will undergo four assessments (once per season) over a one-year period of observation. These assessments
include (1) use of a pedometer with a concealed viewing window for a two-week period to measure walking (2) a study centre
visit during which venous blood is sampled for A1C, anthropometrics are assessed, and questionnaires are completed for
measurement of other factors that may influence walking and/or A1C (e.g. food frequency, depressive symptomology,
medications). The relationship between spring-fall A1C difference and winter-summer difference in steps/day will be examined
through multivariate linear regression models adjusted for possible confounding. Interpretation of findings by researchers in
conjunction with potential knowledge "users" (e.g. health professionals, patient groups) will guide knowledge translation efforts.
Discussion: Although we cannot alter weather patterns to favour active lifestyles, we can design treatment strategies that take
seasonal and weather-related variations into account. For example, demonstration of seasonal variation of A1C levels among
Canadian men and women with T2D and greater understanding of its determinants could lead to (1) targeting physical activity
levels to remain at or exceed peak values achieved during more favourable weather conditions. Strategies may include shifting
to indoor activities or adapting to less favourable conditions (e.g. appropriate outdoor garments, more frequent but shorter
duration periods of activity) (2) increasing dose/number of glucose-lowering medications during the winter and reducing these
during the summer, in anticipation of seasonal variations (3) examining the impact of bright light therapy on activity and A1C
among T2D patients with an increase in depressive symptomology when sunlight hours decline.
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Background
Cardiovascular disease and the importance of glycemic 
control
Cardiovascular disease is the major cause of death in
adults with type 2 diabetes (T2D) [1]. The high glucose
levels of T2D contribute to blood vessel injury and com-
plications such as blindness, kidney failure, heart disease,
and stroke [2]. Although blood glucose levels may be
assessed at a single point in time, hemoglobin A1C better
reflects overall glycemic control and is widely used to
guide diabetes treatment [3]. A1C, reported as the propor-
tion of hemoglobin molecules that are glycosylated, pro-
vides an indication of ambient glucose levels over a two to
three month period, the average life span of a red blood
cell. The United Kingdom Prospective Diabetes Study
(UKPDS) was a landmark clinical trial that demonstrated
strict glycemic control (A1C of 7% achieved by UKPDS
strict arms) to be associated with a greater than 25%
reduction in diabetes-associated complications compared
to then-conventional therapy (A1C of 7.9% achieved by
UKPDS conventional treatment arm) [4,5]. A 1% absolute
increase in A1C is associated with an 18% increased risk
for heart disease or stroke [6]. The Canadian Diabetes
Association (CDA) considers A1C levels of less than 7% to
be acceptable but less than 6% to be optimal [7].
Seemingly small variations in A1C levels are thus of clini-
cal importance. Studies from Japan [8,9], China [10], Swe-
den [11], the United Kingdom [12], and the United States
[13] suggest that in regions with average winter tempera-
tures below 0°C, there is a post-winter to summer A1C
decline of between 0.13% and 0.6% (Table 1). Over time,
a consistent yearly increase in A1C levels, even for a few
weeks, may arguably exert a cumulative adverse impact on
the risk of T2D complications. The issue of seasonal vari-
ation in A1C levels is not addressed by current clinical
practice guidelines [7]. Given the temperature extremes in
many Canadian cities, seasonal variation in A1C levels
may be higher than reported in other settings. Physical
activity is a determinant of A1C that may be particularly
susceptible to seasonal variation. No previous study has
assessed inter-relationships of A1C and physical activity
across seasons.
Seasonal variation: activity in general and walking in 
particular
Seasonal variation in physical activity has been described
in nondiabetic populations. For example, in a commu-
nity-based study conducted in Michigan, the proportion
of respondents reporting no leisure time physical activity
was highest in the winter (32.5%) and fall (28.7%) and
lowest in the spring (23.4%) and summer (17.0%) [14].
In a Massachussetts study, total MET-hours/day increased
by 1.4 (SD = 8.4) among men and 1.0 (SD = 6.0) among
women in July compared to January (24-hour physical
activity recall) [15]. In one survey, adults who perceived
weather as an impediment to walking were three to five
times less likely to walk 120 minutes per week [16]. In a
study conducted by Tudor-Locke and colleagues, during a
one-year period of pedometer self-monitoring in South
Carolina and Tennessee (25 participants, nondiabetic)
[17], participants recorded a mean of 10,082 steps/day,
with 900 more steps/day during the summer compared to
the winter. Interestingly, steps/day was highest in June
and August, but somewhat lower in July, possibly attrib-
utable to extremely warm July temperatures in the south-
ern American states.
Pedometer-based assessments arguably capture nonstruc-
tured physical activity better than do activity question-
naires [18]. Capturing nonstructured activity such as
walking is particularly important among adults with T2D,
among whom 66% report no leisure time physical activity
[19]. Chan and colleages recently used pedometer-based
assessments to assess the impact of climate variables on
steps/day among adults without T2D enrolled in a 12-
week pedometer-based physical activity program in Prince
Edward Island [20]. For an individual taking approxi-
mately 10,000 steps/day, weather-dependent changes in
physical activity could reach 2,000 steps/day, as detailed
below. There was a positive linear relationship between
the number of steps/day and temperature with a 3%
increase in steps/day for every 10°C temperature increase.
Steps/day dropped by 5% over the first 5 mm of rain fall
and 8% at 14 mm of rain. Gender and BMI moderated the
impact of snowfall on walking. At a BMI of 20 kg/m2, men
increased their steps/day by about 20% for the first 10 cm
of snow, while women showed no significant change. At
BMI values of 30 to 35 kg/m2, men had no change in
steps/day while women at these BMI levels experienced a
decline of 7 to 10%.
Potential impact of depressed mood
In addition to imposing physical barriers to walking and
other forms of activity, inclement weather may also
adversely impact mood, possibly reducing motivation to
remain active. Depressed mood has been associated with
poor adherence to diabetes self-care behaviours [21-23],
which may lead to an increase in A1C levels. Seasonal
affective disorder (SAD) is a condition in which depres-
sion occurs with a decline in hours of sunlight [24].
Depressed symptomology not meeting full criteria for
depression have also been shown to have a seasonal vari-
ation in nondiabetic populations [25]. The prevalence of
SAD and/or seasonal variation in depressed mood have
not been examined among adults with T2D. The overall
prevalence of depressive symptoms in T2D is 31% [26].Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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Sex differences
Both prevalence of depressed symptoms and physical
activity levels differ between men and women. Men are
generally less likely to report symptoms of depression [26]
and more likely to be physically active [15,27-31]. Find-
ings from Canada's National Population Health Survey
demonstrate that the presence of children in the house-
hold is a significant deterrent to becoming active for
women but not for men [32]. The most commonly
reported barrier to women's participation in physical
activity is lack of time due to family responsibilities [33-
35]. There may therefore be important gender differences
in seasonal variation of A1C determinants. Neighbour-
hood influences such as safety, lighting, and traffic flow
may impact walking behaviour with safety arguably being
a particularly important factor for women. In addition to
gender, other individual and social factors (e.g. ethnic
background, age, education) may be important in under-
standing walking behaviour [36].
Body weight is a critical determinant of A1C. However,
although body weight has been demonstrated to increase
during the winter months in the nondiabetic population,
the magnitude of this increase is small (<1 kg) [10], and,
if similar among adults with T2D, would be unlikely to
account for seasonal variations in A1C levels. In fact, in a
Japanese study involving 11 insulin-treated T2D patients,
a 0.4% winter-summer A1C difference was detected and
positively associated with a 2 to 3% change in body fat
proportion, but no association with weight change was
observed [9]. Nonetheless, during this study, participants
will be weighed, given that seasonal variation in body
weight has not previously been systematically assessed in
a large observational study among adults with T2D. Car-
bohydrate intake will also be assessed through a food fre-
quency questionnaire. Interestingly, SAD in nondiabetic
populations has been associated with decreased physical
activity and increased carbohydrate cravings [24].
Significance
Examination of environmental factors related to physical
activity was highlighted as a priority research area during
the National Institute of Diabetes and Digestive and Kid-
ney Diseases conference on behavioural science research
in diabetes [37]. Weather may be an important environ-
mental factor. Although we cannot alter weather patterns
to favour active lifestyles, we can design treatment strate-
gies that take seasonal and weather-related variations into
account. For example, demonstration of seasonal varia-
tion of A1C levels among Canadian men and women with
T2D and greater understanding of its determinants could
lead to (1) targeting activity levels to remain at or exceed
peak values achieved during more favourable weather
conditions. Strategies may include shifting to indoor
activities or adapting to less favourable conditions (e.g.
appropriate outdoor garments, more frequent but shorter
duration periods of activity) (2) increasing dose/number
of glucose-lowering medications during the winter and
reducing these during the summer, in anticipation of sea-
sonal variations (3) examining the impact of bright light
therapy on activity and A1C among T2D patients with an
increase in depressive symptomology when sunlight
Table 1: Existing studies addressing seasonal variation in glycemic control.
Design Number Women (%) Location Winter A1C (%) Summer 
A1C (%)
Winter-
summer decline 
in A1C (%)
LETTER
Carney et al, 2000 [12] Retrospective cohort 
study using clinic records
2,080 Not reported Northumberland 
(United Kingdom)
8.4 7.7 0.6 to 0.7 in 
women only
Asplund, 1997 [11] Retrospective cohort 
study using clinic records
800 Not reported Sweden 7.61 7.23 0.38
Ishii et al, 2001 [8] Prospective cohort study 
with monthly A1C
39 69 Fukushima 
province, Japan
6.96 ± 0.9 6.42 ± 0.65 0.54
Sohimiya et al [9] Prospective cohort study 
with monthly A1C
11 0 Japan 6.65 ± 0.12 6.25 ± 0.21 0.40
ARTICLE
Chen et al, 2004* [10] Prospective cohort study 110 25 Taiwan 7.53 ± 1.37 7.31 ± 1.29 0.21 ± 0.94%
Tseng et al, 2005 [13] 
Temp (°C):
Retrospective cohort 
study using database
285,705 veterans. 
Tests:
2.2 United States, 
various areas
87 . 8
>10 117,665 0.07
4.4 to 10 204,001 0.08
0 to 4.4 159,485 0.24
-6.7 to 0 229,239 0.16
-15 to -6.7 77,885 0.13
*In contrast to other studies which assessed a winter-summer difference, this study was concerned with a late winter (February) vs. pre-winter 
(November) difference.Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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hours decline. Depression in individuals with SAD has
been shown to be responsive to bright light therapy [24].
Hypotheses
As illustrated in Figure 1, factors associated with seasonal
weather extremes may have an important impact on walk-
ing activity, leading to deterioration in glucose control
among those with T2D. In Montreal, we postulate that the
lowest levels of walking will occur during winter (January
to March) because of snowfall and low temperatures. The
highest levels of walking will likely occur in spring and
early summer (April to June), a period of warmer temper-
atures and low to moderate humidity. Hemoglobin A1C
(blood test) reflects overall blood glucose levels over the
previous two to three month period (Figure 2). Therefore,
highest A1C levels are expected to occur post-winter
(April–May) following low levels of walking between Jan-
uary and March. Correspondingly, the lowest A1C levels
are anticipated during the summer (July–August), follow-
ing the highest levels of walking between April and June.
Lower levels of sunlight may lead to an increase in depres-
sive symptomology which may reduce activity levels and
diabetes self-care behaviours, resulting in an increase in
A1C. We further expect to find women to have lower lev-
els of walking activity than men, particularly when levels
of depressed mood are high and they feel pressure to jug-
gle competing responsibilities. Other factors that may
impact walking include individual life circumstances and
health status (socioeconomic status, ethnic background,
BMI, diabetes duration) and neighbourhood environ-
mental characteristics (e.g. perceived safety, availability of
sidewalks). Overall activity levels may demonstrate sea-
sonal variation and seasonal impact on A1C levels similar
to that anticipated for walking behaviour.
Objectives
Among ambulatory adults with T2D in Montreal, our pri-
mary objectives are to
1. Estimate the post winter to summer change in glucose
control.
2. Determine whether this change is antedated by a winter
to spring change in walking
3. Determine whether the winter to spring change in walk-
ing differs between men and women
Post winter to summer change in glucose control will be
assessed primarily in terms of change in A1C level, a con-
tinuous variable. In addition, a composite dichotomous
variable, increase in A1C and/or increase in glucose-low-
ering medication, will be examined. This is to account for
Conceptual model Figure 1
Conceptual model. The winter months may be associated with a decline in walking levels leading to an increase in A1C lev-
els. Specific climate factors (low temperature, snowfall, wind chill, decreased sunlight) may account for the decline in walking. 
Change in walking behaviour may differ between men and women, and may be influenced by body mass index, life circum-
stances, neighbourhood environment, and diabetes duration. A winter increase in A1C levels may be attributable not only to a 
decline in walking, but also to a reduction in other activity and/or the presence of depressed mood. Seasonal variation in 
depressed mood has been described in nondiabetic populations. Depressed mood is associated with poor diabetes self-care 
and tends to occur more often among women than among men.Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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the fact that in some instances, treating physicians may
respond to an increase in A1C level by increasing glucose-
lowering medication. As a result, A1C levels may subse-
quently fall. If study evaluation were to occur after medi-
cation adjustment by the treating physician, the initial
deterioration in glucose control would not be detected if
A1C were the only measure of glucose control employed.
Our secondary objectives are to (1) examine changes in
A1C and walking between seasons (i.e. summer-fall, fall-
winter, winter-spring, spring-summer) and (2) ascertain
how selected variables (a) affect A1C levels and/or modify
(b) walking behaviour itself and/or (c) its impact on A1C
levels. These selected variables will include activity other
than walking, specific climate factors (temperature, pre-
cipitation, humidity, hours of sunlight), levels of
depressed mood, individual life circumstances and health
status (work, care for dependents, house keeping, home
maintenance, socioeconomic status, ethnic background,
BMI, diabetes duration), and neighbourhood environ-
mental characteristics (perceived safety, availability of
sidewalks/walking paths, recreational facilities).
Study Design and Methods
Study synopsis
All participants will undergo four assessments (one per
season) over a one-year follow-up period (A1C, anthropo-
metrics, questionnaires, two weeks of pedometer moni-
toring), with the first assessment within three months of
recruitment. The relationship between spring-fall A1C dif-
ference and winter-summer difference in steps/day will be
examined through multivariate linear regression models
adjusted for possible confounding. Interpretation of find-
ings by researchers in conjunction with potential knowl-
edge "users" (e.g. health professionals, patient groups)
will guide knowledge translation efforts.
Eligibility criteria
Participants with a history of at least one year of follow-up
for T2D in Canada are eligible. Large changes in glucose
control may occur during the first year after diagnosis
when dietary counseling and medications are first intro-
duced, potentially obscuring any seasonal variation. In
order to permit accurate steps/day assessment with a ped-
ometer, participants must demonstrate normal gait [38]
and have a BMI ≤ 40 kg/m2 [39]. Individuals with chronic
conditions or medications that may compromise glyc-
emic control are not eligible. Women who are pregnant or
who are planning a pregnancy are also excluded from par-
ticipation. Participants must have an identified health
care provider as diabetes management will not be pro-
vided through the study. Participants must be at least 19
years of age at the time enrollment. There is no upper age
limit to enrollment; however, we anticipate that more eld-
erly individuals may be excluded on the basis of other
exclusion criteria (e.g. gait abnormalities, chronic condi-
tions/medications that may compromise glycemic con-
trol.) All questionnaires and assessments are available in
both English and French.
Recruitment
Recruitment is being conducted through McGill Univer-
sity-associated outpatient clinics (diabetes, internal medi-
cine, family medicine). Participants are approached
directly by our project manager, following an introduc-
tion by a member of the clinic staff (nurse, dietitian,
Hemoglobin A1C level reflects overall glucose control during the previous two to three month period Figure 2
Hemoglobin A1C level reflects overall glucose control during the previous two to three month period. There is therefore a 
delay between low activity levels and developing a high A1C level.Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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receptionist, technician). The project manager then
administers a brief questionnaire to confirm eligibility
and records participant contact information.
Assessment of glucose control
At each assessment, venous blood is sampled for A1C
measurement. A1C levels may be measured in a nonfast-
ing state. The assay being employed is the Bio-Rad Variant
II high-performance liquid chromatography system
(HPLC). This is the most precise A1C assay available [40].
Participants bring their current medication to each visit
and the dose and type of glucose lowering agents is
recorded (metformin, insulin secretagogues, thiazolidine-
dione, insulin).
Walking
Steps/day is being assessed with the Yamax SW-200 ped-
ometer, the less costly version of the Yamax Digi-Walker
SW-701, which displays steps/day within ± 3% of actual
steps taken [41] and provides values within ± 1% of actual
steps at a treadmill speed of 80 m/min [42]. The SW-701
converts steps to calories/distance, a function not required
in the present study. We have purchased 250 pedometers
and have verified the accuracy of each pedometer by com-
paring the pedometer reading with 20 counted steps. Sev-
enty-three percent (182) of the pedometers tested
displayed a value of 20 steps; the remaining 27% (78) dis-
played a value that differed by no more than one step (19
or 21 steps). Participants are trained to maintain the ped-
ometer in a vertical position, clipped to their waistband or
belt. At each assessment, participants are provided with
three zeroed pedometers and a padded courier self-
addressed envelope. The SW-200 has a snap-on plastic
cover that conceals the viewing window. Acetate Security
Seals (Novovision) are placed along the margin where the
cover and pedometer meet. Attempted removal of the seal
results in a serrated edge, making tampering evident. This
discourages participants from checking the number of
steps that they register; during our observational study, we
seek to alter participants' usual behaviour as little as pos-
sible with our measurement tools.
The three pedometers given to each participant at each
visit are labeled as pedometer A, B, and C. During waking
hours, participants (i) wear pedometer A for seven consec-
utive days (ii) wear pedometer B for seven consecutive
days, and then (iii) mail all three pedometers to the study
centre in the padded envelope (courier) provided. Ped-
ometer C provides a measure of the additional steps
recorded as a result of the mailing process. This value will
be deducted from the values recorded on the other two
pedometers at the stage of the analysis. We have opted for
a two-week observation period per season because we
believe that during a shorter period, participants may
endeavour to be more active, potentially masking any sea-
sonal differences. Participants are asked not to use the
pedometer during holiday periods (Christmas, New
Year's, summer vacations) as these may not be represent-
ative of usual walking patterns.
Total activity
Given that our participants will undergo a variety of meas-
ures, it is critical that the tools used for assessment of sec-
ondary outcomes be as user-friendly as possible. Among
the many questionnaires available [43], we have selected
the Short Last 7 Days self-administered format of the
International Physical Activity questionnaire. This two-
page tool includes only seven items, but is structured to
provide separate scores for walking, moderate-intensity
activity, and vigorous-intensity activity. The following val-
ues are used: walking = 3.3 METS, moderate activity = 4.0
METS, and vigorous activity = 8.0 METS. The number of
weekly minutes for each of these categories is derived
from questionnaire responses. Test-retest reliability for
this short questionnaire is good (Spearman's correlation
coefficient 0.66 to 0.88) [44].
Climate variables
Environment Canada collects and archives weather data
from stations across Canada. We have opted to use data
from the Trudeau station, the main weather station in
Montreal. In contrast to smaller substations, at Trudeau
station data are collected everyday at hourly intervals.
Data are extracted from Environment Canada archives by
Dr. I. Strachan (co-investigator, micrometerologist)
monthly and forwarded to our project manager. Variables
of interest include (maximum, minimum and average)
daily temperature, relative humidity, wind speed, rainfall
and snowfall. "Combination" indices such as humidex
and wind chill may also be of importance. Humidex is a
combination of temperature and humidity and is related
to the extra difficulty in heat dissipation under hot humid
air masses. Wind chill describes the extra cooling power of
the wind on a body exposed to already frigid air masses.
Depressed mood
We are using the Center for Epidemiological Studies-
Depression Scale (CES-D) to assess for depressive symp-
toms. Compared to the Beck Depression Inventory, CES-
D has fewer somatic symptoms which may overlap with
physical symptoms related to chronic medical conditions
rather than depressed mood [45]. Respondents indicate
the frequency with which they have experienced each
symptom during the past week on a 4-point scale. A score
of 16 or more indicates a high level of depressive sympto-
mology. Dr. Da Costa (co-investigator, psychologist) has
used this tool previously [46,47]. The Seasonal Pattern
Assessment Questionnaire (SPAQ) assesses mood states
over a 1-year period and would therefore not be appropri-
ate for seasonal tracking [25].Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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Anthropometrics and dietary intake
Weight is assessed to the nearest 0.1 kg (light clothes), and
height to the nearest 0.1 cm (shoes removed). Physical
activity with or without weight loss may be associated
with reduction in intra-abdominal adipose tissue, which
may result in a decreased waist circumference [9,48].
Waist circumference is measured standing, midway
between the lateral lower ribs and the iliac crests [49]. We
administer the Quebec Food Frequency questionnaire at
each visit. This validated tool [50] includes photographs
to assist respondents in assessing quantities of food and
beverage consumed.
Other individual, social, and environmental factors
Our first visit questionnaire queries date of birth, ethnic
background/country of origin, duration of residence in
Canada, education, and occupation using standard ques-
tions from Statistics Canada's Canadian Community
Health Survey. At all four visits, we ask about time spent
in paid and unpaid labour, cooking, housekeeping, home
maintenance, shopping, and childcare based on catego-
ries derived from Statistics Canada's General Social Survey
reports. We enquire about medication use, other medical
conditions, and diabetes duration. Three neighbourhood
social and physical environment surveys have been
reported in the literature to have good test-retest reliability
[51] and items from these surveys, concerning local con-
ditions favouring walking, are included in our first-visit
questionnaire.
Sample size calculation
Our main objective is to estimate the change in A1C post
winter to summer. Table 2 provides the sample sizes
required to accurately measure these changes, where the
accuracy is given by the width of a 95% confidence inter-
val. For example, we expect a seasonal difference of
approximately 0.2% for A1C. We would like to estimate
this to an accuracy of at least ± 0.15, so that the 95% con-
fidence interval will be sufficiently distant from the null
value of 0%. This will ensure that we can rule out "signif-
icant" differences that are not clinically relevant. This will
require a sample size of at least 152 subjects. Our second
major objective is to relate steps/day to glucose control.
There are no previous studies linking steps/day with A1C
levels. In our analysis, we will estimate this association via
hierarchical regression models, while controlling for vari-
ous possible other important factors as well as confound-
ing factors. As a rough rule of thumb [52], for reasonably
accurate estimation, between 10 and 20 subjects are
required per variable added to a regression model.
Our third major objective is to compare the winter-sum-
mer difference in steps/day between men and women.
With 80 men and 80 women we would be able to detect
seasonal differences in steps/day between sexes within
1,100 steps/day (Table 2). Therefore a total sample size of
160 individuals (80 men and 80 women) would ensure
estimation of a winter-summer A1C difference to within
an accuracy of 0.15% while also allowing us to detect sea-
sonal differences in steps/day between sexes within 1,100
steps/day. With 160 subjects we will be able to include
between 8 and 16 independent variables in any one
model. This will provide for good estimation of our pri-
mary association and reasonable control of confounding.
These sample size estimates are conservative, in that they
look only at two seasons even though we will have data
from all four seasons. If trends over the four seasons are
present, we will also be able to estimate these with reason-
able accuracy.
During Dr. Chan's (co-investigator) recent study [20], par-
ticipants were asked to provide 12 consecutive weeks of
pedometer data. Adherence was good for the groups with
which Dr. Chan conducted a baseline one-hour session,
discussing the purpose of the study and the requirements
of the protocol and answering questions. In these groups,
72% of participants provided complete data for 95% of
the days in the 12-week period. In contrast, for the groups
in which there was no face-to-face baseline information
session, only 29% of participants provided complete data
for 95% of the days requested. We carefully explain the
demands of the protocol at baseline. Participants are
asked to monitor walking for four nonconsecutive two-
week periods, arguably less demanding than 12 consecu-
tive weeks. In cohort studies led by Dr. Da Costa (co-
investigator), protocol adherence was encouraged
through lotteries (e.g. bookstore gift certificates, movie
tickets) for those who attend follow-up visits and com-
pleted questionnaires. We conduct similar lotteries during
the present cohort study. Costs of parking/transportation
is also defrayed. Given these factors, we anticipate that at
least 80% of participants will provide adequate pedome-
ter data. Therefore, assuming a maximum loss to follow-
up of 20%, recruitment of 200 individuals (100 men and
100 women) would result in our required sample size of
160 individuals (80 men and 80 women).
Data Analysis
Descriptive analyses will be compiled for all variables col-
lected in the study. Statistics will include means and
standard deviations, medians and inter-quartile ranges,
and proportions, as appropriate. Plots of the main out-
comes (A1C, steps/day) will be created, tracking these var-
iables over time (i.e., over seasons). Ninety-five percent
confidence intervals will be calculated for changes in A1C
and steps/day between seasons. Both univariate and mul-
tivariate regression models will be constructed for the
association between these variables, with post winter to
summer A1C difference as the dependent variable, and
winter to spring/early summer difference in steps/day, asCardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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recorded by pedometer, as the independent variable. Co-
variates and effect modifiers that will be considered will
include gender, depressed mood, work/home responsibil-
ities (time), socio-economic status, climate variables,
BMI, and diabetes duration. In logistic regression models,
the composite outcome of increase in A1C and/or
increase in glucose-lowering medication will be substi-
tuted for the post winter to summer A1C difference as the
dependent variable. We will investigate differences
between men and women in walking activity by calculat-
ing a 95% confidence interval for the mean between-gen-
der difference.
We will handle missing values through multiple imputa-
tion [53]. For each missing data item, we will create a
regression model (typically logistic regression for missing
dichotomous items and linear regression for missing con-
tinuous data) that predicts the missing item based on
related non-missing items from each subject, and general
trends seen in the non-missing data from all subjects. In
this methodology, multiple predictions are made for each
missing item, so that the uncertainty in these predictions
is automatically accounted for in any analyses. Techni-
cally, multiple imputation assumes that the missing data
are ignorable, which in practice assumes that the missing
items are reasonably predicted by the regression models
used. In addition, we will conduct sensitivity analyses to
investigate the impact of having missing data that are not
ignorable. Dr. Joseph (co-investigator, biostatistician) has
extensive experience in developing and implementing
such methods [54,55]. Because there may be considerable
subject to subject variability, we will also use Bayesian
hierarchical modeling. At the first level of this hierarchical
model, the data from each individual over seasons will be
fit. The slopes of the curves of the outcome will then be
regressed on the various possible explanatory factors,
including the seasons, components of the weather, BMI
for each individual, and so on. This will form the second
level of our hierarchical model, and the model will be
completed by using low information prior distributions
for all unknown parameters, allowing the information in
the data to dominate the final posterior distributions [56].
We will use WinBUGS software (Version 1,4.1, Medical
Research Council, Cambridge, U.K.) to estimate all poste-
rior distributions.
Limitations
Some participants may increase their walking as a result of
being monitored. We are therefore concealing the pedom-
eter viewing window with a snap-on cover and a special
seal that make tampering evident. Requiring at least two
weeks of pedometer monitoring/season should provide a
pattern more representative of usual walking patterns
than shorter periods. One challenge will be to ensure con-
tinued adherence to the study protocol. Careful explana-
tion of objectives, incentives, and reimbursement of
transportation costs are anticipated to maximize partici-
pation. The selected pedometers have been shown to be
accurate, but must be worn correctly and require verifica-
tion of position during the day. We anticipate that our
pedometer training sessions and availability of study staff
to respond to questions will help in this regard. Shaking
the pedometer may register steps. We trust that partici-
pants will not do this deliberately, although we cannot
prevent this from occurring. Given that recruitment will
largely occur through a network of diabetes clinics and
associations, we acknowledge that our population will
most likely include individuals with regular contact with
the health care system and therefore may not be entirely
generalizable to those who do not receive regular care.
However, even if we identified potential study candidates
through random digit dialing, we believe that those with
regular contact with the health system would be more
likely to be aware of a diabetes diagnosis and would also
be more likely to be interested in participating in a longi-
tudinal follow-up study.
Ethical approval
The research protocol was given approval by McGill Uni-
versity's Faculty of Medicine Institutional Review Board at
a full board meeting on 27 February 2007 (IRB FWA
00004545). Full board approval for the addition of the
Table 2: Sample size calculations.
Outcome measure Winter-summer difference Standard deviation Reference Desired accuracy (95% CI width) Required sample size
A1C 0.207% 0.943% See Table 1 ± 0.1 342
± 0.15 152
Steps/day
Men 3,629 Estimate: 5,000 Chan et al [20] (data) ± 500 384
± 1,000 96
± 1,100 80
Women 1,106 Estimate: 5,000 Chan et al [20] (data) ± 500 384
± 1,000 96
± 1,100 80Cardiovascular Diabetology 2007, 6:1 http://www.cardiab.com/content/6/1/1
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Food Frequency questionnaire was provided on 28 August
2006.
Knowledge Translation (KT)
Dr. M. De Civita, a health research psychologist with
training and experience in KT theory and practice, is our
KT consultant. KT encompasses a large spectrum of activi-
ties, from discovery of knowledge (innovation) to its
implementation (adoption) in real-world settings. Trans-
lating our results into action will require exchange, synthe-
sis, and application [57-60]. Exchange refers to a two-way
interaction between the knowledge producers (in-team)
and potential users of this knowledge. Our team has close
links to potential users. Dr. Sigal authored the exercise rec-
ommendations in the 2003 Clinical Practice Guidelines of
the Canadian Diabetes Association [61]. Dr. Dasgupta is a
member of the Women Affiliate Program Advisory group,
serving as their expert on women's issues in cardiovascular
health. Dr. Pilote leads GENESIS, an interdisciplinary
pan-Canadian research group concerned with the gender
and sex determinants of cardiovascular disease of which
Dr. Dasgupta is also a member. Dr. Dasgupta will hold
face-to-face meetings with representatives from potential
user groups, who represent the voices of patients, to dis-
cuss (a) the compatibility of research objectives and
expected findings with pre-existing beliefs and attitudes
and (b) the short and long-term goals for knowledge dis-
semination. These meetings will begin early in 2007 (7
February 2007 meeting with the West Island patient chap-
ter of the Canadian Diabetes Association; 12 February
2007 meeting with the Women Affiliate Canadian Health
Network advisory committee in Toronto, Ontario). Syn-
thesis and application of in-team member's knowledge has
been critical to project development and will guide the
interpretation of the findings. The engagement of users in
the interpretation of the findings is another aspect of the
synthesis process. We will work with user group represent-
atives to disseminate the findings to their audiences. Two
meetings will be held wherein the in-team and the repre-
sentatives will discuss how the knowledge should be dis-
seminated, when such knowledge is ready for
dissemination, clear communication of study limitations,
and future research directions to clarify and build upon
the acquired knowledge. Involvement of user groups will
ensure the "contextualization" of the knowledge gener-
ated [62].
Discussion
Extremes of temperature and other climate factors may
reduce walking levels. Among individuals with T2D, this
may have an adverse impact on glycemic control and, ulti-
mately, cardiovascular risk, particularly among women.
Understanding seasonal variation in walking behaviour
may be a key to understanding any seasonal variation in
glycemic control in T2D. Using this knowledge, in collab-
oration with clinicians and representatives from govern-
mental and nongovernmental organizations, we will be
better-positioned to discuss ways to develop gender-spe-
cific programs that modify perceptions of weather as a
barrier to walking and/or offer season-specific activity
programs. Identification of predictable seasonal changes
in glycemic control could also lead to clinical practice
guidelines that advocate for seasonal adjustment of glu-
cose-lowering medication. The benefits to individuals
with T2D may therefore be improved activity programs
and medication recommendations, and ultimately more
effective strategies for the prevention of cardiovascular
disease. Just as understanding of pathophysiology is criti-
cal for the development of diagnostic tests and pharmaco-
logical agents, understanding "pathological" behaviour
specific to environmental and social context is necessary
for the development of context-specific, behavioural
change strategies.
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